The global tissue engineered bone market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to boost the market growth includes technological advancements in the field of 3D tissue engineering, such as replacement of embryo cells with stem cells, organ-on-a-chip technology, and use of 3D bioprinters that can efficiently design in vitro implants. Moreover, an increase in government funding for medical and academic research activities is another factor that is expected to propel the growth of the market during the forecast period. For instance, the April 2019 published list for funding for various research, condition, and disease categories (RCDC) from the National Institutes of Health (NIH), (US) indicates that funding for stem cell research and regenerative medicine was $1.8 and $1 billion respectively in 2018. The NIH estimates for funding in 2020 for these two areas correspond to $1.7 billion, and $915 million respectively. The potential of tissue engineering procedures in treating irreversible damage of tissues has boosted the market growth. In addition, a rise in demand for regenerative medicine and tissue engineering procedures to treat damaged tissues further accelerating the market growth.

Tissue engineering provides alternatives to surgical reconstruction, transplants, and other mechanical devices that are used to repair damaged tissues. The global tissue engineered bone market is also driven by a continuous increase in the need for effective regenerative treatments owing to a rise in the prevalence of diabetes, obesity, and other disorders due to lifestyle changes, aging population, and growing trauma cases. Stem cell therapies have significant potential as therapeutics across various clinical applications. This has resulted in substantial investments in research and clinical translation. Rapid advances in stem cell research aid in improved disease management. Thus, with an increase in the incidence of cancer, diabetes, and other chronic disorders, research on stem cells has increased over the years. There is also an increase in the adoption of single and mixed cells from autologous and allogeneic stem cells, to study their effect on cardiovascular disorders. Furthermore, advancements in tissue engineering technology are expected to boost the market growth. For instance, the development of 3D Engineered Heart Tissue (EHT), and 3D heart muscles would provide potential avenues for the growth of the global tissue engineered bone market.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Type 

o By Application 

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape: Johnson & Johnson Services, Inc., Medtronic plc, Zimmer Biomet Holdings, Inc., among others. 

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Tissue Engineered Bone Market Report by Segment

By Type

• Inorganic Material
• Organic Material
• Composite Material

By Application

• Bone Repair
• Bone Regeneration
• Others

Global Tissue Engineered Bone Market Report by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa